Microfibrillar-Associated Protein 4: A Potential Biomarker for Screening for Liver Fibrosis in a Mixed Patient Cohort

@inproceedings{Skmose2015MicrofibrillarAssociatedP4,
  title={Microfibrillar-Associated Protein 4: A Potential Biomarker for Screening for Liver Fibrosis in a Mixed Patient Cohort},
  author={Susanne Gj\orup S{\ae}kmose and Belinda Klemmensen Moessner and Peer Brehm Christensen and Kristoffer Lindvig and Anders Schlosser and R{\'e}n{\'e} Holst and Torben Barington and Uffe Holmskov and Grith Lykke Sorensen and Mat{\'i}as A. Avila},
  booktitle={PloS one},
  year={2015}
}
BACKGROUND AND AIMS A method for assessment of liver fibrosis and cirrhosis without the need for a liver biopsy is desirable. Microfibrillar-associated protein 4 (MFAP4) is a suggested biomarker for identification of high-risk patients with severe fibrosis stages. This study aimed to examine associations between plasma MFAP4 (pMFAP4) and transient elastography or chronic hepatitis C virus infection in drug users and in a mixed patient cohort with increased risk of liver disease. Moreover, the… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 34 references

Enzyme - linked immunosorbent assay characterization of Basal variation and heritability of systemic microfibrillar - associated protein 4

  • SG Saekmose, A Schlosser, R Holst, SL Johansson, H Wulf-Johansson
  • PLoS One
  • 2013
3 Excerpts

Similar Papers

Loading similar papers…